Tag: ODD

April 20, 2018

Computer Task Group, Incorporated Announces Final Results of its Modified “Dutch Auction” Tender Offer

Computer Task Group Incorporated (NASDAQ:CTG), a leading provider of information technology solutions in North America announced the final results of...
February 28, 2018

Midatech receives Orphan Drug Designation for MTD119 from the European Medicines Agency

Midatech (Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising products in oncology, today announces that the...
February 13, 2018

Abeona Therapeutics Receives FDA Orphan Drug Designation for ABO-202 Gene Therapy Program

Abeona Therapeutics (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic...
February 13, 2018

Abeona Therapeutics Receives FDA Orphan Drug Designation for ABO-202 Gene Therapy Program

Abeona Therapeutics (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic...
February 1, 2018

VIDEO — Duane Nelson: EnviroLeach Technologies and E-Waste Market Potential

Duane Nelson, president and CEO of EnviroLeach Technologies, talks about the potential of the e-waste market and what's ahead for...
December 11, 2017

Cannabis Trends 2017: A New Type of Deal Expanded the Reach of Canadian Producers

INN brings investors old and new to the cannabis space a look back at the year and some of its...
October 25, 2017

Propanc Biopharma Submits US Orphan Drug Designation Request

Propanc Biopharma submitted a request for an orphan drug designation with the US Food and Drug Administration (FDA) for PRP.